Ralf Linker

11PUBLICATIONS
69CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Occupational therapyImmunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 28, 2026
Implementing the 2024 revision of the McDonald diagnostic criteria for multiple sclerosis in Germany: Practical considerations and consensus recommendations.

|Jun 23, 2026
Exploratory crossover field study indicates efficacy and feasibility of light therapy glasses to mitigate fatigue in multiple sclerosis.

|Dec 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases.

Muriel Schraad, Mathias Mäurer, Anke Salmen

|Feb 09, 2024
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?

Olaf Hoffmann, Ralf Gold, Sven G Meuth

|Jun 25, 2023
Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany.

Felix Heinrich, Isabell Cordts, René Günther

|Aug 05, 2022
Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4.

Sven G Meuth, Antonios Bayas, Boris Kallmann

Pageof 2

Frequent Collaborators

3 joint publications

Antonios Bayas

2 joint publications

Mike P Wattjes

2 joint publications

Hans-Peter Hartung

1 joint publications

Frauke Zipp